|
1
|
Sherr CJ: Cancer cell cycles. Science.
274:1672–1677. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sherr CJ and Roberts JM: Living with or
without cyclins and cyclin-dependent kinases. Genes Dev.
18:2699–2711. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Satinder K, Chander SR, Pushpinder K, Indu
G and Veena J: Cyclin D1 (G870A) polymorphism and risk of cervix
cancer: A case control study in north Indian population. Mol Cell
Biochem. 315:151–157. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bartkova J, Lukas J, Strauss M and Bartek
J: The PRAD-1/cyclin D1 oncogene product accumulates aberrantly in
a subset of colorectal carcinomas. Int J Cancer. 58:568–573. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Arber N, Hibshoosh H, Moss SF, Sutter T,
Zhang Y, Begg M, Wang S, Weinstein IB and Holt PR: Increased
expression of cyclin D1 is an early event in multistage colorectal
carcinogenesis. Gastroenterology. 110:669–674. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Maeda K, Chung Y, Kang S, Ogawa M, Onoda
N, Nishiguchi Y, Ikehara T, Nakata B, Okuno M and Sowa M: Cyclin D1
overexpression and prognosis in colorectal adenocarcinoma.
Oncology. 55:145–151. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gillett C, Smith P, Gregory W, Richards M,
Millis R, Peters G and Barnes D: Cyclin D1 and prognosis in human
breast cancer. Int J Cancer. 69:92–99. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Marsh KL and Varley JM: Frequent
alterations of cell cycle regulators in early-stage breast lesions
as detected by immunohistochemistry. Br J Cancer. 77:1460–1468.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Callender T, el-Naggar AK, Lee MS,
Frankenthaler R, Luna MA and Batsakis JG: PRAD-1 (CCND1)/cyclin D1
oncogene amplification in primary head and neck squamous cell
carcinoma. Cancer. 74:152–158. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jares P, Fernández PL, Campo E, Nadal A,
Bosch F, Aiza G, Nayach I, Traserra J and Cardesa A: PRAD-1/cyclin
D1 gene amplification correlates with messenger RNA overexpression
and tumor progression in human laryngeal carcinomas. Cancer Res.
54:4813–4817. 1994.PubMed/NCBI
|
|
11
|
Betticher DC, Heighway J, Hasleton PS,
Altermatt HJ, Ryder WD, Cerny T and Thatcher N: Prognostic
significance of CCND1 (cyclin D1) overexpression in primary
resected non-small cell lung cancer. Br J Cancer. 73:294–300. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shapiro GI, Edwards CD, Kobzik L, Godleski
J, Richards W, Sugarbaker DJ and Rollins BJ: Reciprocal Rb
inactivation and p16INK4 expression in primary lung cancers and
cell lines. Cancer Res. 55:505–509. 1995.PubMed/NCBI
|
|
13
|
Zhou P, Jiang W, Weghorst CM and Weinstein
IB: Overexpression of cyclin D1 enhances gene amplification. Cancer
Res. 56:36–39. 1996.PubMed/NCBI
|
|
14
|
Akkiz H, Bayram S, Bekar A, Akgöllü E and
Ozdil B: Cyclin D1 G870A polymorphism is associated with an
increased risk of hepatocellular carcinoma in the Turkish
population: case-control study. Cancer Epidemiol. 34:298–302. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wong YK, Lin SC, Chang CS, et al: Cyclin
D1 genotype in areca-associated oral squamous cell carcinoma. J
Oral Pathol Med. 32:265–270. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kang S, Kim JW, Park NH, Song YS, Kang SB
and Lee HP: Cyclin D1 polymorphism and the risk of endometrial
cancer. Gynecol Oncol. 97:431–435. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zheng Y, Shen H, Sturgis EM, et al: Cyclin
D1 polymorphism and risk for squamous cell carcinoma of the head
and neck: A case-control study. Carcinogenesis. 22:1195–1199. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kong S, Amos CI, Luthra R, Lynch PM, Levin
B and Frazier ML: Effects of cyclin D1 polymorphism on age of onset
of hereditary nonpolyposis colorectal cancer. Cancer Res.
60:249–252. 2000.PubMed/NCBI
|
|
19
|
Catarino R, Matos A, Pinto D, et al:
Increased risk of cervical cancer associated with cyclin D1 gene
A870G polymorphism. Cancer Genet Cytogenet. 160:49–54. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Thakur N, Hussain S, Kohaar I, et al:
Genetic variant of CCND1: Association with HPV-mediated cervical
cancer in Indian population. Biomarkers. 14:219–225. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Betticher DC, Thatcher N, Altermatt HJ,
Hoban P, Ryder WDJ and Heighway J: Alternate splicing produces a
novel cyclin D1 transcript. Oncogene. 11:1005–1011. 1995.PubMed/NCBI
|
|
22
|
Sawa H, Ohshima TA, Ukita H, Murakami H,
Chiba Y, Kamada H, et al: Alternatively spliced forms of cyclin D1
modulate entry into the cell cycle in an inverse manner. Oncogene.
16:1701–1712. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kong S, Wei Q, Amos CI, Lynch PM, Levin B,
Zong J, et al: Cyclin D1 polymorphism and increased risk of
colorectal cancer at young age. J Natl Cancer Inst. 93:1106–1108.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Porter TR, Richards FM, Houlston RS, Evans
DG, Jankowski JA, Macdonald F, et al: Contribution of cyclin D1
(CCND1) and E-cadherin (CDH1) polymorphisms to familial and
sporadic colorectal cancer. Oncogene. 21:1928–1933. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jiang J, Wang J, Suzuki S, Gajalakshmi V,
Kuriki K, Zhao Y, Nakamura S, Akasaka S, Ishikawa H and Tokudome S:
Elevated risk of colorectal cancer associated with the AA genotype
of the cyclin D1 A870G polymorphism in an Indian population. J
Cancer Res Clin Oncol. 132:193–199. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yaylim-Eraltan I, Arikan S, Yildiz Y,
Cacina C, Ergen HA, Tuna G, Görmüs U, Zeybek U and Isbir T: The
influence of cyclin D1 A870G polymorphism on colorectal cancer risk
and prognosis in a Turkish population. Anticancer Res.
30:2875–2880. 2010.PubMed/NCBI
|
|
27
|
McKay JA, Douglas JJ, Ross VG, Curran S,
Murray GI, Cassidy J, et al: Cyclin D1 protein expression and gene
polymorphism in colorectal cancer. Int J Cancer. 88:77–81. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Forones NM, de Lima JM, de Souza LG and da
Silva ID: Cyclin D1 A870G polymorphism in Brazilian colorectal
cancer patients. J Gastrointest Cancer. 39:118–123. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Siddiqi M, Kumar R, Fazili Z,
Spiegelhalder B and Preussmann R: Increased exposure to dietary
amines and nitrate in a population at high risk of oesophageal and
gastric cancer in Kashmir (India). Carcinogenesis. 13:1331–1335.
1992. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sameer AS, Nissar S, Abdullah S, Chowdri
NA and Siddiqi MA: DNA repair gene 8-oxoguanine DNA glycosylase
Ser326Cys polymorphism and colorectal cancer risk in a Kashmiri
population. DNA Cell Biol. 31:541–546. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sameer AS, Shah ZA, Nissar S, Mudassar S
and Siddiqi MA: Risk of colorectal cancer associated with the
methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism in
the Kashmiri population. Genet Mol Res. 10:1200–1210. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Rasool S, Ganai BA, Kadla SA, Ahanger AG,
Qazi F, Khan T, Rasool V and Masood A: The ECRG1 290Arg/Gln
polymorphism is related to risk of esophageal squamous cell
carcinoma in Kashmir. Asian Pac J Cancer Prev. 12:265–269.
2011.PubMed/NCBI
|
|
33
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
34
|
Javid G, Zargar SA, Rather S, Khan AR,
Khan BA, Yattoo GN, Shah A, Gulzar GM, Sodhi JS, Khan MA and
Shoukat-Deeba Bashir A: Incidence of colorectal cancer in Kashmir
valley, India. Indian J Gastroenterol. 30:7–11. 2011. View Article : Google Scholar
|
|
35
|
Tan XL, Nieters A, Kropp S, et al: The
association of cyclin D1 G870A and E-cadherin C-160A polymorphisms
with the risk of colorectal cancer in a case control study and
meta-analysis. Int J Cancer. 122:2573–2580. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Huang WS, Tang R, Lin PY, Changchien CR,
Chen JS, Chiang JM, Yeh CY, Wang JY and Hsieh LL: Impact of the
cyclin D1 A870G polymorphism on susceptibility to sporadic
colorectalcancer in Taiwan. Dis Colon Rectum. 49:602–608. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhang LQ, Huang X, Wang J, Shang JQ, Bai
J, Liu FY, Guan X and Zhou JN: The cyclin D1 G870A polymorphism and
colorectal cancer susceptibility: A meta-analysis of 20
populations. Asian Pac J Cancer Prev. 12:81–85. 2011.
|
|
38
|
Donnellan R and Chetty R: Cyclin D1 and
human neoplasia. Mol Pathol. 51:1–7. 1998. View Article : Google Scholar
|
|
39
|
Palmqvist R, Stenling R, Oberg A, et al:
Expression of cyclin D1 and retinoblastoma protein in colorectal
cancer. Eur J Cancer. 34:1575–1581. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Pabalan N, Bapat B, Sung L, Jarjanazi H,
Pabalan OF and Ozcelik H: Cyclin D1 Pro241Pro (CCND1-G870A)
polymorphism is associated with increased cancer risk in human
populations: A meta-analysis. Cancer Epidemiol Biomarkers Prev.
17:2773–2781. 2008. View Article : Google Scholar : PubMed/NCBI
|
